07:00 - 08:15 | 310 | CC3 Problematic application of mechanical ventilation | Challenging clinical cases |
07:00 - 08:15 | 311 | CC4 Major challenges in thoracic surgical oncology | Challenging clinical cases |
07:00 - 08:15 | 312 | CC5 Non-resolving pneumonia | Challenging clinical cases |
08:00 - 10:30 | 317 | PD3 Preparing your content for teaching online | Professional development workshop |
08:00 - 10:20 | 318 | SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects | Skills workshop |
08:00 - 10:20 | 319 | SW10 Interventional pulmonology | Skills workshop |
08:30 - 10:30 | 320 | Paediatric Year in Review | Year in review |
08:30 - 10:30 | 321 | Regeneratives approaches to COPD | Symposium |
08:30 - 10:30 | 322 | Diseases and defences of the respiratory mucosa | Symposium |
08:30 - 10:30 | 323 | Yernault Lecture preceded by the symposium “Latest developments in noninvasive ventilation: improvements and gadgets” | Session |
08:30 - 10:30 | 324 | The history of respiratory public health in Britain | Symposium |
08:30 - 10:30 | 325 | An update on pleural empyema diagnostics and treatment | Symposium |
08:30 - 10:30 | 326 | Diagnosing primary ciliary dyskinesia (PCD) in a molecular age | Symposium |
08:30 - 10:30 | 327 | New and old therapies for chronic lung diseases | Oral Presentation |
08:30 - 10:30 | 328 | Lung cancer immunology: latest research | Oral Presentation |
08:30 - 10:30 | 329 | New genomic targets in pulmonary disease | Oral Presentation |
08:30 - 10:30 | 330 | Clinical and microbiological aspects of infections in COPD patients | Oral Presentation |
08:30 - 10:30 | 331 | Asthma: from basic mechanisms to novel therapeutic perspectives | Oral Presentation |
08:30 - 10:30 | 332 | Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea | Oral Presentation |
08:30 - 10:30 | 333 | IPF treatment I | Oral Presentation |
08:30 - 10:30 | 334 | New findings in mucosal immunology | Poster Discussion |
08:30 - 10:30 | 335 | Assessing lower airway inflammation with different tools | Poster Discussion |
08:30 - 10:30 | 336 | Endoscopic lung volume reduction II | Poster Discussion |
08:30 - 10:30 | 337 | Pulmonary hypertension: the clinic I | Poster Discussion |
08:30 - 10:30 | 338 | Measuring physical activity in chronic respiratory disease | Poster Discussion |
08:30 - 10:30 | 339 | Rifampicin resistance, MDRTB, and new drug treatments | Poster Discussion |
10:40 - 13:00 | 347 | SW13 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects | Skills workshop |
10:40 - 13:00 | 348 | SW12 Interventional pulmonology | Skills workshop |
10:45 - 12:45 | 349 | Pulmonary arterial hypertension: future therapeutic approaches | Hot topics |
10:45 - 12:45 | 351 | Influenza and respiratory physicians | Symposium |
10:45 - 12:45 | 352 | Molecular footprints in lung cancer diagnosis and management | Symposium |
10:45 - 12:45 | 353 | State-of-the-art research techniques in Royal Brompton Hospital and Imperial College London II | Session |
10:45 - 12:45 | 354 | Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities | Symposium |
10:45 - 12:45 | 355 | ERS statements and technical standards | Session |
10:45 - 12:45 | 356 | Working together to drive investment and innovation in asthma research | Session |
10:45 - 12:45 | 357 | Late-breaking topics in airways disease | Oral Presentation |
10:45 - 12:45 | 358 | Clinical and molecular studies in asthma | Oral Presentation |
10:45 - 12:45 | 359 | Current challenges in thoracic surgery | Oral Presentation |
10:45 - 12:45 | 360 | Management of asthma and COPD in primary care | Oral Presentation |
10:45 - 12:45 | 361 | COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD | Oral Presentation |
10:45 - 12:45 | 362 | Dyspnoea and respiratory muscle/mechanics anomalies in disease | Oral Presentation |
10:45 - 12:45 | 363 | Electronic cigarettes | Poster Discussion |
10:45 - 12:45 | 364 | Endosonography: EBUS/EUS (B) | Poster Discussion |
10:45 - 12:45 | 365 | Best abstracts in physical activity and telemedicine | Poster Discussion |
10:45 - 12:45 | 366 | Effects of hypoxia and sleep apnoea on the lung, heart, and vessels | Poster Discussion |
10:45 - 12:45 | 367 | IPF: from pathogenesis to treatment II | Poster Discussion |
10:45 - 12:45 | 368 | Active and latent tuberculosis: biomarkers | Poster Discussion |
10:45 - 12:45 | 369 | PD4 How to deal with difficult people | Professional development workshop |
12:50 - 14:40 | 374 | Dealing with the complexity of critically-ill patients | Thematic Poster |
12:50 - 14:40 | 375 | New horizons for noninvasive ventilation in acute and chronic settings | Thematic Poster |
12:50 - 14:40 | 376 | Noninvasive ventilation and beyond: novelties and real-life applications | Thematic Poster |
12:50 - 14:40 | 377 | Multidimensional and multidisciplinary approaches to respiratory problems | Thematic Poster |
12:50 - 14:40 | 378 | Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception | Thematic Poster |
12:50 - 14:40 | 379 | Lung function and imaging: new findings and new approaches | Thematic Poster |
12:50 - 14:40 | 380 | Respiratory muscles and airways function: from physiology to clinical implications | Thematic Poster |
12:50 - 14:40 | 381 | Clinical exercise physiology in health and disease | Thematic Poster |
12:50 - 14:40 | 382 | Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea | Thematic Poster |
12:50 - 14:40 | 383 | Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea | Thematic Poster |
12:50 - 14:40 | 384 | Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders | Thematic Poster |
12:50 - 14:40 | 385 | Effect of sleep apnoea on life-span and comorbidities | Thematic Poster |
12:50 - 14:40 | 386 | Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea | Thematic Poster |
12:50 - 14:40 | 387 | Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome | Thematic Poster |
12:50 - 14:40 | 388 | Pulmonary hypertension: the clinic II | Thematic Poster |
12:50 - 14:40 | 389 | Pulmonary hypertension: exercise, haemodynamics, and physiology | Thematic Poster |
12:50 - 14:40 | 390 | Pulmonary hypertension in lung disease | Thematic Poster |
12:50 - 14:40 | 391 | Acute pulmonary embolism | Thematic Poster |
12:50 - 14:40 | 392 | Pulmonary hypertension and pulmonary embolism: from the bench to the bedside | Thematic Poster |
12:50 - 14:40 | 393 | Surgical strategy for complex diseases | Thematic Poster |
12:50 - 14:40 | 394 | Open problems in thoracic surgery | Thematic Poster |
12:50 - 14:40 | 395 | Long-term outcomes of lung transplantation | Thematic Poster |
12:50 - 14:40 | 396 | Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections | Thematic Poster |
12:50 - 14:40 | 397 | Community-acquired pneumonia: risk classes and management issues | Thematic Poster |
12:50 - 14:40 | 398 | Viral infections in different respiratory conditions: from the bedside to the lab | Thematic Poster |
12:50 - 14:40 | 399 | Microbiological issues and translational research in respiratory infections | Thematic Poster |
12:50 - 14:40 | 400 | Severe respiratory infections in the intensive care unit and pleural and fungal infections | Thematic Poster |
12:50 - 14:40 | 401 | Tuberculosis: the elderly, the diabetic, the unusual, and the severe | Thematic Poster |
12:50 - 14:40 | 402 | Update on drug-resistant tuberculosis | Thematic Poster |
12:50 - 14:40 | 403 | Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers | Thematic Poster |
12:50 - 14:40 | 404 | Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics | Thematic Poster |
12:50 - 14:40 | 405 | Epidemiological insights into tuberculosis pathogenesis | Thematic Poster |
12:50 - 14:40 | 406 | Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) | Thematic Poster |
12:50 - 14:40 | 407 | Microbiology: bronchoalveolar lavage (BAL) and PCR | Thematic Poster |
12:50 - 14:40 | 408 | Epidemiology and specific subgroups in lung cancer | Thematic Poster |
12:50 - 14:40 | 409 | Clinical aspects of lung cancer | Thematic Poster |
12:50 - 14:40 | 410 | Basic science and case reports in lung cancer | Thematic Poster |
12:50 - 14:40 | 411 | Prognostic variables in lung cancer I | Thematic Poster |
12:50 - 14:40 | 412 | Prognostic variables in lung cancer II | Thematic Poster |
12:50 - 14:40 | 413 | Abstracts in medical education, the web and the internet | Thematic Poster |
13:00 - 14:30 | 415 | Interstitial lung disease registry | Lunchtime session |
13:00 - 14:30 | 416 | Lung cancer: latest developments in screening and patient management | Lunchtime session |
13:00 - 14:30 | 417 | When respiratory disease come to an end | Lunchtime session |
13:00 - 14:00 | 423 | ME13 Smoking cessation in difficult population groups | Meet the expert |
13:00 - 14:00 | 424 | ME14 What is sleep apnoea anyway? | Meet the expert |
13:00 - 14:00 | 425 | ME5 Persisting symptoms after pulmonary embolism | Meet the expert |
13:00 - 14:00 | 426 | ME7 Surgery for lung cancer | Meet the expert |
13:00 - 14:00 | 427 | ME6 Dealing with air leaks during noninvasive ventilation | Meet the expert |
13:00 - 14:00 | 428 | ME8 Acute and chronic infection in chronic obstructive pulmonary disease | Meet the expert |
13:00 - 14:30 | 433 | PD5 Establishing core facilities for measuring clinical trial outcomes | Professional development workshop |
14:30 - 16:50 | 446 | SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects | Skills workshop |
14:30 - 16:50 | 447 | SW14 Interventional pulmonology | Skills workshop |
14:45 - 16:45 | 448 | GR3 Scientific Grand Round: precision medicine | Grand round |
14:45 - 16:45 | 449 | Air pollution and effects on lung health | Hot topics |
14:45 - 16:45 | 450 | Updating on electronic nicotine delivery systems (ENDS) or e-cigarettes | Symposium |
14:45 - 16:45 | 451 | Driving and sleepiness | Symposium |
14:45 - 16:45 | 452 | Historical landmarks in respiratory medicine: contributions from the UK | Symposium |
14:45 - 16:45 | 453 | New therapies for chronic respiratory infections | Symposium |
14:45 - 16:45 | 454 | Deep phenotyping to improve treatment outcomes in paediatric asthma | Symposium |
14:45 - 16:45 | 455 | Recent high impact findings regarding COPD comorbidities | Oral Presentation |
14:45 - 16:45 | 456 | Pulmonary hypertension: novel insights | Oral Presentation |
14:45 - 16:45 | 457 | Advancements in bronchoscopy | Oral Presentation |
14:45 - 16:45 | 458 | Sepsis and ARDS: looking forward | Oral Presentation |
14:45 - 16:45 | 459 | Phenotyping asthma | Oral Presentation |
14:45 - 16:45 | 460 | Latent tuberculosis infection | Oral Presentation |
14:45 - 16:45 | 461 | Novel approaches for pulmonary rehabilitation in chronic lung diseases | Oral Presentation |
14:45 - 16:45 | 462 | New insights into noninvasive ventilation: between the dream and reality | Poster Discussion |
14:45 - 16:45 | 463 | Quality management and quality of life in lung cancer | Poster Discussion |
14:45 - 16:45 | 464 | ILD pathogenesis | Poster Discussion |
14:45 - 16:45 | 465 | Prevalence, prognosis, and risk factors of COPD | Poster Discussion |
14:45 - 16:45 | 466 | Highlights in primary ciliary dyskinesia and asthma in childhood | Poster Discussion |
14:45 - 16:45 | 467 | Paediatric bronchology II | Poster Discussion |
17:30 - 19:00 | 487 | Industry Evening Mini Symposium at ERS 2016: “Challenges in the management of non-CF bronchiectasis” | Evening Mini Symposium |